Process for preparing 3alpha(beta)-7alpha(beta)-dihydroxy-6a lpha(beta)-alkyl-5beta-cholanic acid

Details for Australian Patent Application No. 2006248906 (hide)

Owner Intercept Pharmaceuticals, Inc.

Inventors Pellicciari, Roberto; Ferrari, Massimo

Agent Fisher Adams Kelly

Pub. Number AU-B-2006248906

PCT Pub. Number WO2006/122977

Priority MI2005A000912 19.05.05 IT

Filing date 19 May 2006

Wipo publication date 23 November 2006

Acceptance publication date 12 April 2012

International Classifications

C07J 9/00 (2006.01) Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

A61K 31/575 (2006.01) - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/122977 Priority application(s): WO2006/122977

10 February 2011 Assignment before Grant

  Erregierre S.p.A. The application has been assigned to Intercept Pharmaceuticals, Inc. 2007

12 April 2012 Application Accepted

  Published as AU-B-2006248906

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006248938-Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase

2006248902-Composition for treatment of a detached retina and method of production thereof